All News

A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.

Oral vitamin D supplementation, in addition to asthma medications, could reduce the risk of asthma attacks requiring hospital attendance by 50%, according to a recently-published study in The Lancet of Respiratory Medicine.

Achieving National HIV/AIDs target goal could prevent an estimated 200,000 deaths over 20 years, according to a study recently published in the Journal of Infectious Diseases.

Payers and manufacturers look for specialty pharmacy partners with several key aspects.

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

The Express Scripts Medicare Value and Choice plans cover up to 75% of costs after the deductible for specialty drugs.

Reducing the cost of antiretroviral therapy could produce even more savings in the treatment of HIV.

Delay that start of insulin therapy can threaten overall health and cause diabetes-related complications.

Top news of the day from across the health care landscape.

Neutrophil-related proteins may protect the brain against damage and disability from intracranial hemorrhagic stroke.

Top news of the day from across the healthcare landscape.

Opioid therapies are often prescribed for sleep disturbance due to their effect on multiple neurochemical pathways associated with sleep.

Two different Copaxone injection doses approved for relapsing forms of multiple sclerosis.

OnabotulinumtoxinA is a prescription medication that works by injection into the muscles to treat frontalis muscle activity.

Patients with chronic kidney disease are at risk for several comorbid conditions, including cardiovascular disease.

Vaccination offers protection from harmful diseases, such as hepatitis B, measles and pertussis, and pharmacists can counsel parents.

Social media has become a crucial tool for organizations and businesses to interact with their customers and discuss the services they offer. Many Americans look to social media for recommendations and to build stronger relationships with the brands they use.

Patients who develop chronic kidney disease (CKD) are at risk for a number of comorbidities, including cardiovascular decline.

Medicare Part D premiums expected to decrease for the first time since 2012.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Medicare and individual insurance enrollment changed for Americans affected by Hurricanes Harvey, Irma, and Maria.

Ramping up programs for injection drug users is a key part in preventing transmission of hepatitis C.

Exosomes from obese mice induce insulin resistance in healthy animals.

Top news of the day from across the health care landscape.

Aegerion Pharmaceuticals pleads guilty to several claims regarding cholesterol drug lomitapide (Juxtapid).

Top news of the day from across the healthcare landscape.

The neurodegenerative phase of multiple sclerosis remains a significant challenge for researchers.

Nearly one-quarter of AARP survey respondents reported sleep troubles 3 or more nights a week and use a prescription sleep aid.

FDA officials have approved onabotulinumtoxinA (BOTOX Cosmetic, Allergan) for its third indication for the temporary improvement in the appearance of moderate-to-severe forehead lines associated with frontalis muscle activity in adults.

According to an "FDA in Brief" report, officials with the FDA received an adverse event report on August 14, 2017, from a physician concerning a patient who was diagnosed postoperatively with bilateral hemorrhagic occlusive retinal vasculitis (HORV).